Lv2
120 积分 2024-03-05 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms
2个月前
已完结
The biology of VEGF and its receptors
2个月前
已完结
PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases
4个月前
已完结
CCL2/MCP-1在其相关疾病的机制研究
8个月前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
1年前
已完结
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies
1年前
已完结
Biomarkers for antibody-drug conjugates in solid tumors
1年前
已完结
皖公网安备34019202002308
